Episode
Discussing RA: UPA outcomes and the impact of GCs on targeted therapies in RA
- Podcast
- The IMID Forum
- Published
- Dec 18, 2025
- Duration seconds
- 1350
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-upa-outcomes-and-the-impact-of-gcs-on-targeted-therapies-in-ra/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-upa-outcomes-and-the-impact-of-gcs-on-targeted-therapies-in-ra.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he and Doctor Reike Alten will be reviewing two papers. The first paper by Kameda et al. assessed long-term safety and efficacy of UPA over 5 years in Japanese patients with moderate-to- severe active RA and an inadequate response to stable doses of csDMARDs-IR. The second paper by Salvato et al. assessed the impact of chronic oral low-dose GCs on the efficacy and retention rates of JAK inhibitors compared to other mechanisms of action therapies in a cohort of RA patients with inadequate response to TNFi.